Myllia Biotechnology
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Myllia Biotechnology operates in Healthcare & Life Sciences and is based in Vienna. It was founded in 2018.
Myllia Biotechnology is a biotechnology company that specializes in functional genomics by combining CRISPR-based perturbations with single-cell RNA sequencing to accelerate drug target discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myllia Biotechnology Comparables
Compare Myllia Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Algen Biotechnologies | 86% | |
| Scenic Biotech | 84% | |
| Engine Biosciences | 82% |
For institutional investors. Book with your work email.
Myllia Biotechnology Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 30% MoM, reaching 4.9K.
- Mar 2, 2026
Monthly visitors grew 72% MoM, reaching 19.4K.
For institutional investors. Book with your work email.
Myllia Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Myllia Biotechnology's valuation, stock price, and market status.
Is Myllia Biotechnology a public or private company?
Myllia Biotechnology is a private company.
What is the current stock price of Myllia Biotechnology?
Myllia Biotechnology is a private company, so its shares have no public market price. Caplight tracks Myllia Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Myllia Biotechnology worth (valuation)?
Valuation information for Myllia Biotechnology is not publicly available.
Can I buy Myllia Biotechnology stock?
Myllia Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Myllia Biotechnology's last funding round?
Funding round information for Myllia Biotechnology is not publicly available.
Who are the main investors in Myllia Biotechnology?
Investor information for Myllia Biotechnology is not publicly disclosed.
Will Myllia Biotechnology IPO soon?
No public IPO plans have been announced for Myllia Biotechnology.
How can I track Myllia Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Myllia Biotechnology's shares on secondary markets.